Filing Flows › Idexx Laboratories (IDXX) › Q3 2025
Idexx Laboratories (IDXX) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 3, 2025
Idexx Laboratories (IDXX) reported revenue of $1.1B for the third quarter 2025 (Q3 2025), +13% from a year earlier and -0.4% from the quarter before. Operating margin was 32.1%, net earnings $275M (24.8% of revenue).
Idexx Laboratories, Q3 2025: revenue $1.1B (+13% year over year), operating margin 32.1%, net earnings $275M, operating cash flow $402M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1B | -0.4% | +13% |
| Gross profit | $683M | -2% | +15% |
| Operating profit | $355M | -5% | +17% |
| Net earnings | $275M | -7% | +18% |
| Operating cash flow | $402M | +117% | +83% |
| Free cash flow | $371M | +145% | +93% |
What changed
Revenue was $1.1B in Q3 2025, up 13% year over year and roughly flat from the previous quarter. Product revenue was the largest line at 59% of revenue. Product revenue added $0.09B year over year (up 16%), 68% of the total change.
Gross margin was 61.8%, up 0.7 points from a year earlier. Operating profit was $0.35B, a 32.1% margin (up 1.0 points year over year). Of the extra revenue versus a year earlier, 39% reached operating profit, above the 31% margin then. Operating expenses grew 12% against revenue growth of 13%. The fastest-growing cost line was Research & development (+17%). Net earnings were $0.27B, up 18% year over year. The effective tax rate was 20.4%.
Operating cash flow was $0.40B (up 83% year over year), 147% of net earnings. Non-cash charges added back $0.04B of depreciation and amortization and $0.01B of share-based compensation. Working capital and other items added $0.08B. Capital expenditures of $0.03B left free cash flow of $0.37B.
Questions
What was Idexx Laboratories' revenue in the third quarter 2025?
Idexx Laboratories (IDXX) reported revenue of $1.1B for the third quarter 2025 (Q3 2025), +13% from a year earlier and -0.4% from the quarter before.
Was Idexx Laboratories profitable in the third quarter 2025?
Operating profit was $355M (32.1% of revenue) and net earnings $275M.
Source: Idexx Laboratories 10-Q on SEC EDGAR.